Atrial natriuretic peptide, Arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients

Neuropsychobiology

Volumn 67, Issue 2, 2013, Pages 111-115

  Glahn, Alexander ^a   Heberlein, Annemarie ^a   Dürsteler Macfarland, Kenneth M ^d   Lenz, Bernd ^b   Frieling, Helge ^a   Gröschl, Michael ^b   Wiesbeck, Gerhard A ^d   Kornhuber, Johannes ^b   Bönsch, Dominikus ^c   Bleich, Stefan ^a   Hillemacher, Thomas ^a  

^a Social Psychiatry and Psychotherapy   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Psychiatric Hospital Rickling   (Germany)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Arginine vasopressin peptide; Atrial natriuretic peptide; Cortisol; Craving; Opiate dependence; Opiate maintenance; Stress

Indexed keywords

ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; DIAMORPHINE; HYDROCORTISONE; ALCOHOL; COCAINE; METHADONE; OPIATE;

ADULT; ARGININE VASOPRESSIN PEPTIDE BLOOD LEVEL; ARTICLE; ATRIAL NATRIURETIC PEPTIDE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAINTENANCE THERAPY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; PSYCHOMETRY; WITHDRAWAL SYNDROME; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROBIOLOGY; PROTEIN BLOOD LEVEL; STRESS;

ADULT; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; HEROIN; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; PSYCHOMETRICS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84873591765     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000346110     Document Type: Article

References (24)

1. Koob GF: The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 2006; 101(suppl 1):23-30.
2. Franken IH, Hendriksa VM, van den Brink W: Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav 2002; 27: 675-685.
3. Wigger A, Sanchez MM, Mathys KC, Ebner K, Frank E, Liu D, Kresse A, Neumann ID, Holsboer F, Plotsky PM, Landgraf R: Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology 2004; 29: 1-14.
4. Zhou Y, Leri F, Cummins E, Hoeschele M, Kreek MJ: Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology 2008; 33: 226-236.
5. Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ: Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 1999; 63: 324-331.
6. van Ree JM, Burbach-Bloemarts EM, Wallace M: Vasopressin neuropeptides and acquisition of heroin and cocaine self-administration in rats. Life Sci 1988; 42: 1091-1099.
7. Hillemacher T, Frieling H, Luber K, Yazici A, Muschler M, Lenz B, Wilhelm J, Kornhuber J, Bleich S: Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal. Psychoneuroendocrinology 2009; 34: 555-560.
8. Kiefer F, Andersohn F, Jahn H, Wolf K, Raedler TJ, Wiedemann K: Involvement of plasma atrial natriuretic peptide in protracted alcohol withdrawal. Acta Psychiatr Scand 2002; 105: 65-70.
9. Döring WK, Herzenstiel MN, Krampe H, Jahn H, Pralle L, Sieg S, Wegerle E, Poser W, Ehrenreich H: Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcohol Clin Exp Res 2003; 27: 849-861.
10. Landgraf R: Neuropeptides in anxiety modulation. Handb Exp Pharmacol 2005; 169: 335-369.
11. Ströhle A, Feller C, Strasburger CJ, Heinz A, Dimeno F: Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide. Psychoneuroendocrinology 2006; 31: 1127-1130.
12. Antoni FA, Hunter EF, Lowry PJ, Noble JM, Seckl JR: Atriopeptin: an endogenous corticotropin- release inhibiting hormone. Endocrinology 1992; 130: 1753-1755.
13. Gerber H, Borgwardt SJ, Schmid O, Gerhard U, Joechle W, Riecher-Rössler A, Wiesbeck GA, Walter A: The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence. Eur Addict Res 2012; 18: 116-123.
14. Bonfiglio JJ, Insa C, Refojo D, Holsboer F, Arzt E, Silberstein S: The corticotropin-releasing hormone network and the hypothalamic- pituitary-adrenal axis: molecular and cellular mechanisms involved. Neuroendocrinology 2011; 94: 12-20.
15. Facchinetti F, Volpe A, Farci G, Petraglia F, Porro CA, Barbieri G, Cioni A, Balestrieri A, Genazzani AR: Hypothalamus-pituitaryadrenal axis of heroin addicts. Drug Alcohol Depend 1985; 15: 361-366.
16. Ho WKK, Wen HL, Fung KP, Ng YH, Au KK, Ma L: Comparison of plasma hormonal levels between heroin addicted and normal subjects. Clin Chim Acta 1977; 75: 415-419.
17. Holsboer F, Barden N: Antidepressants and HPA regulation. Endocr Rev 1996; 17: 187-205.
18. Holsboer F, Ising M: Stress hormone regulation: biological role and translation into therapy. Annu Rev Psychol 2010; 61: 81-109.
19. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M: Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption. Addiction 1993; 88: 791-804.
20. Tiffany ST, Carter BL, Singleton EG: Challenges in the manipulation, assessment and interpretation of craving relevant variables. Addiction 2000; 95: 177-187.
21. Wiedemann K, Jahn H, Yassouridis A, Kellner M: Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide- induced panic attacks: preliminary findings. Arch Gen Psychiatry 2001; 58: 371-377.
22. Ohashi M, Fujio N, Nawata H, Kato K, Matsubayashi S, Tamai H, Matsuo H, Ibayashi H: Human atrial natriuretic polypeptide in plasma of patients with anorexia nervosa. Horm Metab Res 1988; 20: 705-708.
23. Ströhle A, Holsboer F: Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 2003; 36: 207-214.
24. Walter M, Wiesbeck GA, Degen B, Albrich J, Oppel M, Schulz A, Schächinger H, Dürsteler- MacFarland KM: Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients. Addict Biol 2011; 16: 145-151.